Important studies have pointed out that by regulating the expression of specific miRs, c-Met orchestrates the convergence of several EMT-associated pathways, including Dicer, SRC, PKC-ε and AKT, suggesting the possibility that c-Met targeting could be a strategy to control EMT and cancer progression. Here, MET is linked to cancer.